Briacell Therapeutics Corp
BCTX10.220USD
+0.140+1.39%
收盤 11/05, 16:00（美東）報價延遲15分鐘
19.25M總市值
虧損本益比TTM
關於 Briacell Therapeutics Corp 公司
BriaCell Therapeutics Corp. 是一家臨牀階段的生物技術公司，致力於開發新型免疫療法來改變癌症治療。其 3 期主要候選藥物 Bria-IMT 是一種獲得專利的、現成的、基於細胞的靶向免疫療法，可激活患者的免疫系統，專門殺死癌細胞而不會傷害其他細胞。該公司正在推進其 Bria-IMT 靶向免疫療法與免疫檢查點抑制劑 (Retifanlimab) 的聯合治療，以治療轉移性乳腺癌的關鍵 3 期研究。該公司還在開發個性化的現成免疫療法 Bria-OTS 和 Bria-OTS+，這爲開發針對多種癌症的個性化現成免疫療法提供了平臺技術，以及一種可溶性 CD80 蛋白療法，它既可以作爲免疫系統的刺激劑，也可以作爲免疫檢查點抑制劑。其管道還包括 Bria-IMT + CPI、Bria-BRES/BRES+、Bria-PROS+、Bria-LUNG+ 和 Bria-MEL+。
Briacell Therapeutics Corp簡介
公司代碼BCTX
公司名稱Briacell Therapeutics Corp
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
員工數量17
證券類型Ordinary Share
年結日Oct 12
公司地址Suite 300 - Bellevue Centre, 235 -15th Street
城市WEST VANCOUVER
上市交易所NASDAQ Capital Market Consolidated
國家Canada
郵編V7T 2X1
電話16049211810
網址https://briacell.com/
公司代碼BCTX
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
Briacell Therapeutics Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.13K
-96.81%
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
799.00
-25.81%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
163.00
+36.97%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
18.00
-99.81%
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
-100.00%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
--
-100.00%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
--
-100.00%
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
--
-100.00%
名稱
名稱/職務
職務
持股
持股變動
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.13K
-96.81%
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
799.00
-25.81%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
163.00
+36.97%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
18.00
-99.81%
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
-100.00%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月18日 週六
更新時間: 10月18日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Heights Capital Management, Inc.
5.31%
Iroquois Capital Management, LLC
2.97%
L5 Capital Inc.
0.92%
Lynwood Capital Management Inc.
0.57%
3I Management LLC
0.49%
其他
89.74%
持股股東
持股股東
佔比
Heights Capital Management, Inc.
5.31%
Iroquois Capital Management, LLC
2.97%
L5 Capital Inc.
0.92%
Lynwood Capital Management Inc.
0.57%
3I Management LLC
0.49%
其他
89.74%
股東類型
持股股東
佔比
Investment Advisor
5.39%
Hedge Fund
2.97%
Investment Advisor/Hedge Fund
1.26%
Corporation
0.92%
Individual Investor
0.20%
Research Firm
0.03%
其他
89.22%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
57
182.01K
9.66%
+123.64K
2025Q2
65
831.24K
7.95%
-645.60K
2025Q1
68
476.26K
7.27%
-513.92K
2024Q4
65
403.53K
10.88%
-198.25K
2024Q3
64
441.30K
30.40%
+131.88K
2024Q2
63
437.48K
31.09%
+121.43K
2024Q1
62
332.09K
21.52%
-17.16K
2023Q4
67
402.86K
34.69%
+35.57K
2023Q3
74
369.20K
35.11%
-158.11K
2023Q2
84
434.95K
41.59%
-338.84K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Heights Capital Management, Inc.
100.00K
5.31%
+100.00K
--
Jul 15, 2025
Iroquois Capital Management, LLC
56.00K
2.97%
+56.00K
--
Jul 21, 2025
L5 Capital Inc.
17.40K
0.92%
+450.00
+2.65%
Dec 10, 2024
Lynwood Capital Management Inc.
10.65K
0.57%
+114.00
+1.08%
Mar 31, 2024
3I Management LLC
9.17K
0.49%
-27.73K
-75.15%
Mar 31, 2025
Sabby Management, LLC
3.95K
0.21%
+3.95K
--
Jun 30, 2025
UBS Financial Services, Inc.
1.52K
0.08%
-383.00
-20.08%
Jun 30, 2025
Williams (William V)
35.30K
1.87%
+28.26K
+401.29%
Aug 01, 2025
Bondarenko (Jamieson)
1.08K
0.06%
+278.00
+34.79%
Dec 09, 2024
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
公告日期
類型
比率
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
